What is the Treatment editor Ingredient dialog used for?

back

The optional Treatment Ingredient dialog displays any ingredient information that is entered in the F9 validation list for treatment name. The ingredient dialog can also be used to calculate a pre-mix rate that contains a specified quantity of an ingredient. If the Ingredient dialog is not visible in the treatment editor, display the Treatment View Options dialog by selecting Tools from the ARM menu bar, then Options and click Treatment View tab. Deselect the check mark for the “Hide ingredients dialog” option. The treatment view options also controls other settings related to the treatment editor window.

The treatment ingredient dialog displays “No ingredient information” when the cursor is positioned on a treatment line for which it is not possible to obtain ingredient information from the treatment name F9 validation list. (The treatment name field is called Entry Name, Product Name, Practice/Product, or Entry/Trt. Description on some study definitions.)

Ingredient information is entered in the comment section of the treatment name validation list. Position the cursor in the treatment name field and press F9. Any ingredient information is listed at the right side of the validation list dialog following the entries for treatment name, formulation concentration, etc.

The comment must be formatted correctly for pre-mix ingredient information (names + concentrations) to list it as an ingredient on the treatment ingredient dialog.

Items in each ingredient comment section are separated by a plus sign "+". ARM will assume that a comment in a chemical dictionary is the ingredient listing for a pre-mix if the comment is formatted as:

First ingredient name+Second ingredient name|Amount+Amount

For more details on validation list formatting, please refer to the ARM help topic, Validation List Item Format.

 

Last Updated January 03, 2008

                                          

                        Copyright © 1997-2008 Gylling Data Management, Inc.